Patrys Limited announced the appointment, effective from 13 April 2015, of Dr. James Campbell as Managing Director and Chief Executive Officer. Dr. Campbell, who was appointed as a Non-Executive Director of Patrys in November 2014, has more than 20 years of international biotechnology management and leadership experience and has been involved in the creation and/or transformation of several Australian and international biotechnology companies. Dr. Campbell will commence by leading a strategic review of the Company's operations, exploring opportunities to strengthen the company's development portfolio and focusing on investor relations. Dr. Campbell's role will initially be part-time, but is expected to progressively expand into a full-time role over the coming six months. Mr. Roger McPherson, who has been acting as Interim CEO, will provide close assistance to Dr. Campbell during this initial period in the expanded role of
Chief Operating Officer. Dr. Campbell was previously the COO and CFO of ChemGenex Pharmaceuticals Limited, with responsibilities ranging from business development through to IP management and including finance and governance. More recently Dr. Campbell was actively involved in the creation, through acquisition, of Invion Limited as an executive director and remains a non-executive director of that company.